Increased serum chemerin levels associated with carotid intima-media thickness

Caner Feyzi Demir1, İklimya Nimet Ataş2, Ferhat Balgetir1

  • 1Firat University, Faculty of Medicine, Department of Neurology, Elazig, Turkey.

Insights

Elevated chemerin levels are linked to increased carotid intima-media thickness (CIMT), a marker of atherosclerosis. This suggests chemerin may play a role in the development of cerebrovascular disease.

Area of Science:

  • Cardiovascular Research
  • Neuroscience
  • Biochemistry

Background:

  • Chemerin, a protein, is implicated in inflammatory processes contributing to atherosclerosis.
  • While elevated chemerin predicts ischemic cerebrovascular disease, its association with atherosclerosis severity is unclear.

Purpose of the Study:

  • To investigate the relationship between serum chemerin levels and carotid intima-media thickness (CIMT).
  • To assess chemerin's role in generalized atherosclerosis using CIMT as a biomarker.

Main Methods:

  • Carotid Doppler ultrasonography was used to measure CIMT in 40 ischemic stroke patients and 40 controls.
  • Serum chemerin levels were quantified in all participants.
  • CIMT measurements were standardized and averaged from both common carotid arteries.

Main Results:

  • Serum chemerin levels were significantly higher in stroke patients compared to healthy controls (p=0.004).
  • A positive correlation was observed between serum chemerin levels and CIMT (p<0.05).
  • Carotid intima-media thickness was significantly greater in the patient group (p<0.001).

Conclusions:

  • Elevated serum chemerin levels are associated with increased CIMT.
  • Findings suggest a potential link between chemerin and the pathogenesis of atherosclerotic ischemic cerebrovascular disease.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
305
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
588
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
317